IDO1 and melanoma: Previous studies showed that Melanoma-derived Wnt5a promotes the transcriptional expression of IDO1 in nearby DCs by Wnt5a-β-catenin signaling and activates the PPAR-γ signaling pathway, culminating in enhanced IDO1 activity to establish an immunosuppressive microenvironment [52].